7 January 2021

The European Commission has granted the company a conditional marketing authorisation to Moderna for its Covid-19 vaccine candidate. This will accelerate the rollout of Moderna’s vaccine across the European Union. The European Medicines Agency recommended the use of the two dose mRNA Covid-19 vaccine for active immunisation in individuals aged 18 years and older.

The Russian Direct Investment Fund has entered an agreement with Serbia where the former will supply two million doses of the Sputnik V vaccine to fight coronavirus to the country. The Sputnik V vaccination programmes commenced in Serbia on 6 January 2021 after the first doses of Sputnik V arrived on 30 December 2020.

University of Maryland School of Medicine researchers are expected to participate in a Phase III clinical trial of NVX-CoV2373, an investigational Covid-19 vaccine. The trial will test the safety and efficacy of the vaccine candidate that is being developed by Novavax

Morocco’s Ministry of Health announced that it has approved the use of the AstraZeneca/Oxford Covid-19 vaccine for a year. A Covid-19 advisory committee had met on December 31 in Morocco’s capital Rabat to discuss the authorisation of the vaccine in the country. The committee analysed the vaccine’s safety and efficacy and international data that supports its standards and use and in its preclinical and clinical stage trials.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.